<p>The FDA is adding a new warning label onto GLP-1 drugs like Ozempic and Zepbound for a rare side effect with serious risk.&nbsp; All GLP-1 drug makers will now be required to include new safety warnings informing patients that the medications could increase risk of sudden vision loss from a condi</p>